https://www.selleckchem.com/pr....oducts/Staurosporine
24 to 3.46). No subjects eligible for certification as visually impaired or blind were reported. Conclusions Secondary prevention of visual disability due to retinopathy is currently the sole purpose of national eye screening programmes globally. However, the rarity of treatment-requiring retinopathy in children/young people living with diabetes, alongside growing concerns about suboptimal screening uptake, merit new consideration of the utility of screening for primary prevention of diabetes-related morbidity by using the screeni